ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 162 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $3,473,000 | +28.8% | 935,987 | 0.0% | 0.04% | +29.6% |
| Q4 2017 | $2,696,000 | -35.9% | 935,987 | 0.0% | 0.03% | -43.8% |
| Q3 2017 | $4,203,000 | +33.9% | 935,987 | +36.9% | 0.05% | +23.1% |
| Q2 2017 | $3,138,000 | +1229.7% | 683,619 | +2241.6% | 0.04% | +875.0% |
| Q3 2016 | $236,000 | +3.5% | 29,194 | 0.0% | 0.00% | -20.0% |
| Q2 2016 | $228,000 | +1.3% | 29,194 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $225,000 | -32.4% | 29,194 | -5.3% | 0.01% | -44.4% |
| Q4 2015 | $333,000 | +56.3% | 30,844 | 0.0% | 0.01% | +50.0% |
| Q3 2015 | $213,000 | -20.5% | 30,844 | +1.8% | 0.01% | -14.3% |
| Q2 2015 | $268,000 | -50.8% | 30,300 | -45.2% | 0.01% | -50.0% |
| Q1 2015 | $545,000 | +20.3% | 55,250 | -7.6% | 0.01% | +7.7% |
| Q2 2014 | $453,000 | -45.1% | 59,800 | -40.7% | 0.01% | -94.1% |
| Q2 2013 | $825,000 | – | 100,891 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
| RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
| TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
| DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
| Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
| Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
| Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
| Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
| Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
| Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |